Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is effective and safe for treating severe alopecia areata for up to 5 years.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

Stopping heptaminol medication reversed hair color loss in a patient on dialysis.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Retinol palmitate may reduce cancer relapses in early-stage lung cancer patients.

EGFR inhibitors for lung cancer can cause severe skin issues.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Baricitinib may reactivate trichilemmal cysts in people with a history of these cysts.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.

Baricitinib reduces inflammation and improves cell health in premature aging cells.

Folliculin slows hair growth, and blocking it might help treat hair loss.

Prolactin slows down hair growth in mice.

Some JAK inhibitors are effective for significant hair regrowth in alopecia areata.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Colchicine can inhibit hair growth by affecting cell activity and protein expression in hair follicles.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

Baricitinib is effective and safe for treating severe alopecia areata.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Hedgehog pathway inhibitors used for skin cancer can cause significant hair loss, which may improve after stopping the medication.

Platelet lysate effectively promotes hair growth and improves hair thickness in people with androgenetic alopecia.

Oral tofacitinib effectively regrows hair in children with alopecia areata without major side effects.